These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3058875)

  • 1. A new biomarker in monitoring breast cancer: CA 549.
    Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
    J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring breast cancer with CA 549.
    Chan DW; Beveridge RA; Bruzek DJ; Damron DJ; Bray KR; Gaur PK; Ettinger DS; Rock RC
    Clin Chem; 1988 Oct; 34(10):2000-4. PubMed ID: 3168211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
    Colomer R; Ruibal A; Salvador L
    Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.
    Colomer R; Ruibal A; Genollá J; Rubio D; Del Campo JM; Bodi R; Salvador L
    Breast Cancer Res Treat; 1989 Mar; 13(2):123-33. PubMed ID: 2730960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
    Safi F; Kohler I; Röttinger E; Beger H
    Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites.
    De Wit R; Hoek FJ; Bakker PJ; Veenhof CH
    J Intern Med; 1991 May; 229(5):463-6. PubMed ID: 2040873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
    Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma.
    Verdi CJ; Ahmann FR; Schifman RB; Elvick AL; Ahmann ME; Marx PC
    Cancer; 1993 Jun; 71(11):3625-32. PubMed ID: 8490911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of tumor markers CA 15-3 and CEA in breast cancer].
    Buck I; Lindner C; Böge K; Kitschke HJ
    Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA 125 in malignant effusions in breast cancer.
    Kandylis K; Vassilomanolakis M; Baziotis N; Papadimitriou A; Tsoussis S; Ferderigou A; Efremidis AP
    Ann Oncol; 1990 Nov; 1(6):435-8. PubMed ID: 2083187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in breast cancer: on the diagnostic value of serum determinations in clinical freedom from tumor and manifest disease].
    Günczler P; Ogris E; Maca S; Danmayr E
    Onkologie; 1989 Oct; 12(5):209-14. PubMed ID: 2685686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological markers for metastatic breast cancer.
    Ng JS; Sturgeon CM; Seth J; Paterson GM; Roulston JE; Leonard RC
    Dis Markers; 1993 Dec; 11(5-6):217-23. PubMed ID: 8082311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study.
    Martoni A; Zamagni C; Bellanova B; Zanichelli L; Vecchi F; Cacciari N; Strocchi E; Pannuti F
    Eur J Cancer; 1995 Sep; 31A(10):1615-21. PubMed ID: 7488411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEA and CA 15-3 in primary and recurrent breast cancer.
    O'Dwyer PJ; Duffy MJ; O'Sullivan F; McDermott E; Losty P; O'Higgins NJ
    World J Surg; 1990; 14(5):562-5; discussion 565-6. PubMed ID: 2238654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer.
    Hou MF; Chen YL; Tseng TF; Lin CM; Chen MS; Huang CJ; Huang YS; Hsieh JS; Huang TJ; Jong SB; Huang YF
    Kaohsiung J Med Sci; 1999 Sep; 15(9):520-8. PubMed ID: 10561976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.